Manuel Comabella Lopez Dr. Manuel Comabella earned his medical degree at the University of Barcelona, completed his neurology residency at the Neurology Department of the Hospital Universitari Vall d’Hebron (HUVH), and earned his PhD at the Universitat Autònoma de Barcelona. Since 2004, Dr. Manuel Comabella is the Head of the Clinical Neuroimmunology laboratory at the Fundació Institut de Recerca del HUVH. Since June 2008 he works as a clinical neurologist at the Department of Neurology / Neuroimmunology of the MS Centre of Catalonia (Cemcat), HUVH, Barcelona. Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Responsable Laboratori Multiple Sclerosis Centre of Catalonia Email Manuel Comabella Lopez Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca Responsable Laboratori Multiple Sclerosis Centre of Catalonia Dr. Manuel Comabella earned his medical degree at the University of Barcelona, completed his neurology residency at the Neurology Department of the Hospital Universitari Vall d’Hebron (HUVH), and earned his PhD at the Universitat Autònoma de Barcelona. Since 2004, Dr. Manuel Comabella is the Head of the Clinical Neuroimmunology laboratory at the Fundació Institut de Recerca del HUVH. Since June 2008 he works as a clinical neurologist at the Department of Neurology / Neuroimmunology of the MS Centre of Catalonia (Cemcat), HUVH, Barcelona.
From 1996 to 1998, Dr. Manuel Comabella was a Research Fellow in Neuroimmunology at the Center for Neurologic Diseases, Brigham and Women´s Hospital, in Boston. In 2010 was awarded with the Ayudas Merck Serono in the multiple sclerosis research area. In 2011 was awarded by the Spanish Society of Neurology (SEN) with the Biogen Idec Prize to the best publication on demyelinating disorders. In 2013 was awarded by the SEN with the Novartis Prize to the best oral communication and the best publication on demyelinating disorders. In 2014 received the Neurological Disorders Award, scientific modality, granted by the SEN. In 2016 was awarded with the Ayudas Merck Serono in the multiple sclerosis research area. From 2018 to 2020, Dr. Manuel Comabella was a collaborator of the Biomedicine area at the Division of Coordination, Evaluation and Scientific and Technical Follow-up of the State Research Agency, Ministry of Science, Innovation and Universities. Dr. Manuel Comabella is member of the Editorial Board of Journal of Neuroimmunology and Multiple Sclerosis Journal, member of the Board of the ESNI (European School of Neuroimmunology), and member of the Strategic Group of the IMSGC (International Multiple Sclerosis Genetics Consortium). He is coauthor of 297 documents indexed in MedLine (Scopus: 12916 total citations, with h-index of 54). Dr. Manuel Comabella's research interest lies in the identification of biomarkers related with different aspects of multiple sclerosis and the development of new therapeutic strategies for the disease.
Projects Differential Expression of HLA-DQ. In multiple sclerosis patients who are non-responsive to treatment with Interferon. IP: Manuel Comabella Lopez Collaborators: - Funding agency: Dana Foundation Funding: 76279.58 Reference: DANA-01-2006 Duration: 01/10/2006 - 01/10/2009 Estudio de genes candidatos en regiones de susceptibilidad para la esclerosis múltiple IP: Manuel Comabella Lopez Collaborators: Mar Tintore Subirana Funding agency: Instituto de Salud Carlos III Funding: 131890 Reference: PI061906 Duration: 01/01/2007 - 30/06/2010 Análisis proteómico en líquido cefaloraquídeo y suero de pacientes con síndromes clínicos aislados sugestivos de esclerosis múltiple IP: Mar Tintore Subirana Collaborators: Manuel Comabella Lopez, Xavier Montalban Gairín Funding agency: Instituto de Salud Carlos III Funding: 141015 Reference: PI050588 Duration: 01/01/2006 - 31/01/2009 Red Española de Esclerosis Múltiple (perteneciente a la Red CIEN C03/06): Desarrollo de marcadores biológicos y clínicos de la respuesta al tratamiento con Interferón beta en esclerosis múltiple. IP: Xavier Montalban Gairín Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Carmen Espejo Ruiz Funding agency: Instituto de Salud Carlos III Funding: 714 Reference: PI052145 Duration: 01/01/2006 - 31/12/2006 Pagination First page « Previous page ‹ … Page 7 Page 8 Page 9 Current page 10 Page 11 Next page › Last page »
